Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Diabetes, Obesity and Metabolism, 2024
The causal relationship between plasma protein‐to‐protein ratios and type 2 diabetes and its complications: Proteomics mendelian randomization study

Zhang Y., Chen B., Yang Q. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Journal of Affective Disorders, 2024
Integrating genetic and proteomic data to elucidate the association between immune system and blood-brain barrier dysfunction with multiple sclerosis risk and severity

Sun D., Wang R., Du Q. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Nature, 2024
Inhibition of IL-11 signalling extends mammalian healthspan and lifespan

Widjaja A., Lim W., Viswanathan S. et al.

Olink Target 96AgingPathophysiologyCell Culture Supernatant

Clinical Cancer Research, 2024
Novel Combinations of Immunotherapies or DNA Damage Repair Inhibitors in Platinum-Refractory Extensive-Stage Small Cell Lung Cancer: The Phase II BALTIC Study

Reinmuth N., Juan-Vidal O., Kowalski D. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Clinical Kidney Journal, 2024
Multiomic profiling of new-onset kidney function decline: insights from the STANISLAS study cohort with a 20-year follow-up

Dupont V., Xhaard C., Behm-Ansmant I. et al.

Olink Target 96NephrologyPatient StratificationPlasma

Cell Reports Medicine, 2024
Aberrant bowel movement frequencies coincide with increased microbe-derived blood metabolites associated with reduced organ function

Johnson-Martínez J., Diener C., Levine A. et al.

Olink Target 96Wellness StudiesPathophysiologyPlasma

Translational Oncology, 2024
Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study

Borgmästars E., Ulfenborg B., Johansson M. et al.

Olink Target 96OncologyPatient StratificationPlasma

Rejuvenation Research, 2024
Exploring the Expression Profiles of Serum Inflammatory Proteins and Potential Antiaging Targets in Chinese Long-Living People

Liu J., Zhu Q., Zhang D. et al.

Olink Target 96AgingPathophysiologyPatient StratificationSerum

Journal of Investigative Dermatology, 2024
Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1

Farag A., Visvanathan S., Bachelez H. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Medicine, 2024
Causal relationship between inflammatory markers and left ventricle geometry and function: A 2-sample Mendelian randomization study

Lai B., Huang B., Li L.

Olink Target 96CVDPathophysiologyPlasma

Frontiers in Immunology, 2024
Exploring causal correlations between circulating cytokines and atopic dermatitis: a bidirectional two-sample Mendelian randomization study

Xuan Z., Chen X., Zhou W. et al.

Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasma

Journal of Proteome Research, 2024
Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in Atopic Dermatitis

Monedeiro F., Ehall B., Tiffner K. et al.

Olink Target 48Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologyPlasmaInterstitial Fluid

Nature, 2024
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus

Law C., Wacleche V., Cao Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Nature Aging, 2024
Blood protein assessment of leading incident diseases and mortality in the UK Biobank

Gadd D., Hillary R., Kuncheva Z. et al.

Olink Explore 3072/384AgingPatient StratificationPlasma

International Journal of Surgery, 2024
Exploring potential plasma drug targets for cholelithiasis through multiancestry Mendelian randomization

Liu X., Shi L., Zhang S. et al.

Olink Explore 3072/384Other Diseases & SyndromesPathophysiologyPlasma

Neurology, 2024
Prediction of Future Parkinson Disease Using Plasma Proteins Combined With Clinical-Demographic Measures

You J., Wang L., Wang Y. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Brain, Behavior, and Immunity, 2024
Spinal cord injury disrupts plasma extracellular vesicles cargoes leading to neuroinflammation in the brain and neurological dysfunction in aged male mice

Lei Z., Krishnamachary B., Khan N. et al.

Olink Target 96 MouseNeurologyAgingPathophysiologyEV Lysate

Biomedical Chromatography, 2024
Plasma metabolites and inflammatory proteins profiling predict outcome of Fufang Duzhong Jiangu granules treating Kashin–Beck disease

Deng X., Niu H., Zhang Q. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma

JCI Insight, 2024
Protein biomarker signature in patients with spinal and bulbar muscular atrophy

Tebbenkamp A., Huggett S., Lombardi V. et al.

Olink Explore 3072/384Olink Target 96 MouseNeurologyPathophysiologyPlasmaMouse PlasmaSerum

Skin Research and Technology, 2024
The causal relationship between immune cells mediating FIT3L, CCL4, OSM, and skin‐derived deteriorated tumors

Gong W., Zhou J., Hou Y. et al.

Olink Target 96OncologyPathophysiologyPlasma

3119 publications